|
1
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bianco P, Riminucci M, Gronthos S and
Robey PG: Bone marrow stromal stem cells: Nature, biology, and
potential applications. Stem Cells. 19:180–192. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Coffelt SB, Marini FC, Watson K, Zwezdaryk
KJ, Dembinski JL, LaMarca HL, Tomchuck SL, Honer zu Bentrup K,
Danka ES, Henkle SL, et al: The pro-inflammatory peptide LL-37
promotes ovarian tumor progression through recruitment of
multipotent mesenchymal stromal cells. Proc Natl Acad Sci USA.
106:3806–3811. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Asahara T, Masuda H, Takahashi T, Kalka C,
Pastore C, Silver M, Kearne M, Magner M and Isner JM: Bone marrow
origin of endothelial progenitor cells responsible for postnatal
vasculogenesis in physiological and pathological
neovascularization. Circ Res. 85:221–228. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Malek S, Kaplan E, Wang JF, Ke Q, Rana JS,
Chen Y, Rahim BG, Li M, Huang Q, Xiao YF, et al: Successful
implantation of intravenously administered stem cells correlates
with severity of inflammation in murine myocarditis. Pflugers Arch.
452:268–275. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Campbell JJ and Butcher EC: Chemokines in
tissue-specific and microenvironment-specific lymphocyte homing.
Curr Opin Immunol. 12:336–341. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Von Lüttichau I, Notohamiprodjo M,
Wechselberger A, Peters C, Henger A, Seliger C, Djafarzadeh R, Huss
R and Nelson PJ: Human adult CD34− progenitor cells
functionally express the chemokine receptors CCR1, CCR4, CCR7,
CXCR5, and CCR10 but not CXCR4. Stem Cells Dev. 14:329–336. 2005.
View Article : Google Scholar
|
|
8
|
Dvorak HF: Tumors: Wounds that do not
heal. Similarities between tumor stroma generation and wound
healing. N Engl J Med. 315:1650–1659. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kidd S, Caldwell L, Dietrich M, Samudio I,
Spaeth EL, Watson K, Shi Y, Abbruzzese J, Konopleva M, Andreeff M,
et al: Mesenchymal stromal cells alone or expressing
interferon-beta suppress pancreatic tumors in vivo, an effect
countered by anti-inflammatory treatment. Cytotherapy. 12:615–625.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Spaeth EL, Dembinski JL, Sasser AK, Watson
K, Klopp A, Hall B, Andreeff M and Marini F: Mesenchymal stem cell
transition to tumor-associated fibroblasts contributes to
fibrovascular network expansion and tumor progression. PLoS One.
4:e49922009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang Q, Liu XZ, Kang CS, Wang GX, Zhong Y
and Pu PY: The anti-glioma effect of suicide gene therapy using
BMSC expressing HSV/TK combined with overexpression of Cx43 in
glioma cells. Cancer Gene Ther. 17:192–202. 2010. View Article : Google Scholar
|
|
12
|
Cavarretta IT, Altanerova V, Matuskova M,
Kucerova L, Culig Z and Altaner C: Adipose tissue-derived
mesenchymal stem cells expressing prodrug-converting enzyme inhibit
human prostate tumor growth. Mol Ther. 18:223–231. 2010. View Article : Google Scholar :
|
|
13
|
Karnoub AE, Dash AB, Vo AP, Sullivan A,
Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R and Weinberg
RA: Mesenchymal stem cells within tumour stroma promote breast
cancer metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin WR, Brittan M and Alison MR: The role
of bone marrow-derived cells in fibrosis. Cells Tissues Organs.
188:178–188. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rhodes LV, Muir SE, Elliott S, Guillot LM,
Antoon JW, Penfornis P, Tilghman SL, Salvo VA, Fonseca JP, Lacey
MR, et al: Adult human mesenchymal stem cells enhance breast
tumorigenesis and promote hormone independence. Breast Cancer Res
Treat. 121:293–300. 2010. View Article : Google Scholar
|
|
16
|
Kemp KC, Hows J and Donaldson C: Bone
marrow-derived mesenchymal stem cells. Leuk Lymphoma. 46:1531–1544.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Wang M, Abarbanell AM, Weil BR,
Herrmann JL, Tan J, Novotny NM, Coffey AC and Meldrum DR: MEK
mediates the novel cross talk between TNFR2 and TGF-EGFR in
enhancing vascular endothelial growth factor (VEGF) secretion from
human mesenchymal stem cells. Surgery. 146:198–205. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Scherzed A, Hackenberg S, Froelich K,
Kessler M, Koehler C, Hagen R, Radeloff A, Friehs G and Kleinsasser
N: BMSC enhance the survival of paclitaxel treated squamous cell
carcinoma cells in vitro. Cancer Biol Ther. 11:349–357. 2011.
View Article : Google Scholar
|
|
19
|
Park JI: Growth arrest signaling of the
Raf/MEK/ERK pathway in cancer. Front Biol (Beijing). 9:95–103.
2014. View Article : Google Scholar
|
|
20
|
Whyte J, Bergin O, Bianchi A, McNally S
and Martin F: Key signalling nodes in mammary gland development and
cancer. Mitogen-activated protein kinase signalling in experimental
models of breast cancer progression and in mammary gland
development. Breast Cancer Res. 11:2092009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dhillon AS, Hagan S, Rath O and Kolch W:
MAP kinase signalling pathways in cancer. Oncogene. 26:3279–3290.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scherzed A, Hackenberg S, Radeloff A,
Froelich K, Rak K, Hagen R and Kleinsasser N: Human mesenchymal
stem cells promote cancer motility and cytokine secretion in vitro.
Cells Tissues Organs. 198:327–337. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh
K, Bae YC and Jung JS: Characterization and expression analysis of
mesenchymal stem cells from human bone marrow and adipose tissue.
Cell Physiol Biochem. 14:311–324. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rangan SR: A new human cell line (FaDu)
from a hypopharyngeal carcinoma. Cancer. 29:117–121. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zenner HP, Lehner W and Herrmann IF:
Establishment of carcinoma cell lines from larynx and submandibular
gland. Arch Otorhinolaryngol. 225:269–277. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Witz IP: Tumor-microenvironment
interactions: Dangerous liaisons. Adv Cancer Res. 100:203–229.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zigrino P, Löffek S and Mauch C:
Tumor-stroma interactions: Their role in the control of tumor cell
invasion. Biochimie. 87:321–328. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen Z, Malhotra PS, Thomas GR, Ondrey FG,
Duffey DC, Smith CW, Enamorado I, Yeh NT, Kroog GS, Rudy S, et al:
Expression of proinflammatory and proangiogenic cytokines in
patients with head and neck cancer. Clin Cancer Res. 5:1369–1379.
1999.PubMed/NCBI
|
|
29
|
Kanazawa T, Nishino H, Hasegawa M, Ohta Y,
Iino Y, Ichimura K and Noda Y: Interleukin-6 directly influences
proliferation and invasion potential of head and neck cancer cells.
Eur Arch Otorhinolaryngol. 264:815–821. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lederle W, Depner S, Schnur S, Obermueller
E, Catone N, Just A, Fusenig NE and Mueller MM: IL-6 promotes
malignant growth of skin SCCs by regulating a network of autocrine
and paracrine cytokines. Int J Cancer. 128:2803–2814. 2011.
View Article : Google Scholar
|
|
31
|
Cohen S, Bruchim I, Graiver D, Evron Z,
Oron-Karni V, Pasmanik-Chor M, Eitan R, Bernheim J, Levavi H,
Fishman A, et al: Platinum-resistance in ovarian cancer cells is
mediated by IL-6 secretion via the increased expression of its
target cIAP-2. J Mol Med Berl. 91:357–368. 2013. View Article : Google Scholar
|
|
32
|
Chang H, Shi Y, Tuokan T, Chen R and Wang
X: Expression of aquaporin 8 and phosphorylation of Erk1/2 in
cervical epithelial carcinogenesis: Correlation with
clinicopathological parameters. Int J Clin Exp Pathol. 7:3928–3937.
2014.PubMed/NCBI
|
|
33
|
Hsu YL, Hou MF, Kuo PL, Huang YF and Tsai
EM: Breast tumor-associated osteoblast-derived CXCL5 increases
cancer progression by ERK/MSK1/Elk-1/snail signaling pathway.
Oncogene. 32:4436–4447. 2013. View Article : Google Scholar
|
|
34
|
Shi Y, Hsu JH, Hu L, Gera J and
Lichtenstein A: Signal pathways involved in activation of p70S6K
and phosphorylation of 4E-BP1 following exposure of multiple
myeloma tumor cells to interleukin-6. J Biol Chem. 277:15712–15720.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Levy DE and Darnell JE Jr: Stats:
Transcriptional control and biological impact. Nat Rev Mol Cell
Biol. 3:651–662. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rose-John S, Scheller J, Elson G and Jones
SA: Interleukin-6 biology is coordinated by membrane-bound and
soluble receptors: Role in inflammation and cancer. J Leukoc Biol.
80:227–236. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Qiao L, Xu Z, Zhao T, Zhao Z, Shi M, Zhao
RC, Ye L and Zhang X: Suppression of tumorigenesis by human
mesenchymal stem cells in a hepatoma model. Cell Res. 18:500–507.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu Y, Sun Z, Han Q, Liao L, Wang J, Bian
C, Li J, Yan X, Liu Y, Shao C, et al: Human mesenchymal stem cells
inhibit cancer cell proliferation by secreting DKK-1. Leukemia.
23:925–933. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu R, Wei S, Chen J and Xu S: Mesenchymal
stem cells in lung cancer tumor microenvironment: Their biological
properties, influence on tumor growth and therapeutic implications.
Cancer Lett. 353:145–152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Direkze NC, Hodivala-Dilke K, Jeffery R,
Hunt T, Poulsom R, Oukrif D, Alison MR and Wright NA: Bone marrow
contribution to tumor-associated myofibroblasts and fibroblasts.
Cancer Res. 64:8492–8495. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mishra PJ, Mishra PJ, Humeniuk R, Medina
DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW and Banerjee D:
Carcinoma-associated fibroblast-like differentiation of human
mesenchymal stem cells. Cancer Res. 68:4331–4339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Silzle T, Kreutz M, Dobler MA, Brockhoff
G, Knuechel R and Kunz-Schughart LA: Tumor-associated fibroblasts
recruit blood monocytes into tumor tissue. Eur J Immunol.
33:1311–1320. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Koukourakis MI, Giatromanolaki A, Harris
AL and Sivridis E: Comparison of metabolic pathways between cancer
cells and stromal cells in colorectal carcinomas: A metabolic
survival role for tumor-associated stroma. Cancer Res. 66:632–637.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
De Wever O and Mareel M: Role of tissue
stroma in cancer cell invasion. J Pathol. 200:429–447. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Qiao L, Xu ZL, Zhao TJ, Ye LH and Zhang
XD: Dkk-1 secreted by mesenchymal stem cells inhibits growth of
breast cancer cells via depression of Wnt signalling. Cancer Lett.
269:67–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
